Humana reported second-quarter earnings that exceeded analyst expectations, with adjusted earnings per share of $7.61 versus the expected $7.22, and revenue of $40.87 billion beating estimates. The company maintained its 2026 adjusted profit outlook of at least $9 per share, citing stable medical and pharmacy cost trends and strength in its insurance and healthcare services units. Despite the solid results, shares fell over 4% in premarket trading, as investors were disappointed by the unchanged profit guidance amid rising medical costs in Medicare Advantage plans. Humana expects medical costs to remain stable next year and aims to improve profitability through plan changes and membership growth, targeting a sustainable pretax margin of at least 3% by 2028.
Humana reported a second-quarter net income of $694 million, driven by a surge in Medicare Advantage enrollees to 7.1 million, up from 5.8 million a year ago. Despite rising medical costs industry-wide, Humana managed to keep its benefit ratio at 91....
A securities fraud lawsuit against Humana Inc. and its former CEO and CFO is proceeding after a judge ruled key claims valid. The lawsuit alleges that from July 2022 to October 2024, Humana misled investors about rising healthcare utilization costs, ...
This week, U.S. markets focus on the Federal Reserve's July meeting, key inflation data like Core PCE, and second-quarter GDP figures, alongside major tech earnings from Microsoft, Meta, Apple, and Amazon. Rising oil prices and geopolitical tensions ...
